Literature DB >> 9272686

Differential effects of dimethyl sulfoxide on nicotinic acetylcholine receptors from mouse muscle and Torpedo electrocytes.

M J Eaton1, O R Pagán, R M Hann, V A Eterović.   

Abstract

The present study examined the effects of 0.1% dimethyl sulfoxide (DMSO) on nicotinic acetylcholine receptors (nAChR) from mouse muscle and Torpedo californica electrocytes. Receptors were expressed in Xenopus laevis oocytes and studied with voltage-clamp. When applied simultaneously with acetylcholine, DMSO did not inhibit current amplitude of either receptor. Preincubation with DMSO for 1 min reduced current amplitude by approximately 50% from oocytes expressing electrocyte receptor. Preincubation did not affect the muscle receptor. With electric organ membranes, 0.1% DMSO did not block either [alpha-(125)I]bungarotoxin binding to the nAChR agonist site or [3H]phencyclidine binding to its high affinity site on resting or desensitized receptor. These data suggest that DMSO might be affecting the electrocyte receptor through a second messenger system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9272686     DOI: 10.1016/s0304-3940(97)00505-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Determinants of phencyclidine potency on the nicotinic acetylcholine receptors from muscle and electric organ.

Authors:  V A Eterović; R Lu; A E Eakin; A D Rodríguez; P A Ferchmin
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

2.  Antagonism of ATP responses at P2X receptor subtypes by the pH indicator dye, Phenol red.

Authors:  Brian F King; Min Liu; Andrea Townsend-Nicholson; Jürg Pfister; Fernando Padilla; Anthony P Ford; Joel R Gever; Ian B Oglesby; Stephanie Schorge; Geoffrey Burnstock
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

3.  Propofol and AZD3043 Inhibit Adult Muscle and Neuronal Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes.

Authors:  Malin Jonsson Fagerlund; Johannes Krupp; Michael A Dabrowski
Journal:  Pharmaceuticals (Basel)       Date:  2016-02-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.